Platelet-Derived Growth Factor-A Overexpression Correlates with Atrial Fibrosis in the Patients with Atrial Fibrillation Secondary to Rheumatic Valvular Disease
- 1 Department of Cardiology, Xi’an Central Hospital, Xi’an, China
- 2 Medical College of Yan’an University, Yan’an, China
- 3 Medical College of Yan’an University, Yan’an, China
- 4 Medical College of Yan’an University, Yan’an, China
- 5 Department of Cardiology, Xi’an Central Hospital, Xi’an, China
- 6 Department of Cardiology, Xi’an Central Hospital, Xi’an, China
Abstract
Objective: To investigate the relationship between platelet-derived growth factor-A (PDGF-A) and atrial fibrosis in patients who have developed atrial fibrillation (AF) secondary to rheumatic valvular disease. Methods: 84 selected patients participated in the current study who have developed rheumatic heart disease and were going to have a cardiac surgical operation. In the current study, whole subjects were divided into two group, they were atrial fibrillation (AF) group (the quantity is thirty-nine) and sinus rhythm (SR) group (the quantity is forty-five). Before the operation, complete clinical data was available for the whole patients. During the operation, the right atrial tissue (0.3 - 0.5 mm 3 ) was disserted from every patient. Right atrial fibrosis was observed by Masson staining and the distribution of PDGF-A in right atrium specimen was observed by immunohistochemistry. RT-PCR techniques were applied to admeasure the mRNA expressions of PDGF-A in patients’ atrial tissue. At the same time, western-Blot techniques were employed to admeasure the protein expressions of PDGF-A. Results: In baseline clinical characteristics, in both AF group and SR group, there was no apparently difference between them (P > 0.05); compared with SR group, the diameters of left atrium and right atrium in AF group were apparently increased (P < 0.05). The results of Masson staining revealed that the atrial tissue fibrosis was clearer in AF group, and collagen volume fraction in the AF group was evidently exceeding SR group (P < 0.05). The expressions of PDGF-A’s mRNA and protein from right atrial tissue in the AF group were evidently greater than SR group (P < 0.05). The mRNA and protein expressions of PDGF-A and the right atrium diameter go hand in hand. Conclusion: Atrial remodeling plays an important role in patients with valvular atrial fibrillation; PDGF-A in patients with AF was highly expressed in the right atrial, and was closely related with atrial fibrosis.
- Koniari, I., Artopoulou, E., Velissaris, D., et al. (2021) Biomarkers in the Clinical Management of Patients with Atrial Fibrillation and Heart Failure. Journal of Geriatric Cardiology, 18, 908-951.
- Qi, M.M., Qian, L.L. and Wang, R.X. (2021) Modulation of SK Channels: Insight into Therapeutics of Atrial Fibrillation. Heart, Lung & Circulation, 30, 1130-1139. https://doi.org/10.1016/j.hlc.2021.01.009
- Haim, M., et al. (2015) Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients with Incident Non-Valvular Atrial Fibrillation. Journal of the American Heart Association, 4, e001486. https://doi.org/10.1161/JAHA.114.001486
- Goya, W.S., Olia, P., Lucy, L., et al. (2021) Adult Height and Incidence of Atrial Fibrillation and Heart Failure in Older Men: The British Regional Heart Study. IJC Heart & Vasculature, 35, Article ID: 100835. https://doi.org/10.1016/j.ijcha.2021.100835
- Zafrir, B., Lund, L.H., Laroche, C., et al. (2018) Prognostic Implications of Atrial Fibrillation in Heart Failure with Reduced, Mid-Range, and Preserved Ejection Fraction: A Report from 14964 Patients in the European Society of Cardiology Heart Failure Long-Term Registry. European Heart Journal, 39, 4277-4284. https://doi.org/10.1093/eurheartj/ehy626
- Hiroko, I., Shigeru, M., Yoshiki, S. and Yoshiki, S. (2021) Cardiac Fibrosis Models Using Human Induced Pluripotent Stem Cell-Derived Cardiac Tissues Allow Anti-Fibrotic Drug Screening in Vitro. Stem Cell Research, 54, Article ID: 102420. https://doi.org/10.1016/j.scr.2021.102420
- Zou, R., Zhang, D., Lv, L., et al. (2019) Bioinformatic Gene Analysis for Potential Biomarkers and Therapeutic Targets of Atrial Fibrillation-Related Stroke. Journal of Translational Medicine, 17, Article No. 45. https://doi.org/10.1186/s12967-019-1790-x
- Li, Y.C., Zhang, R.J., Hu, N.W. and Li, N.S. (2021) Atrial Fibrosis Underlying Atrial Fibrillation (Review). International Journal of Molecular Medicine, 47, Article No. 9. https://doi.org/10.3892/ijmm.2020.4842
- Koniari, I., Artopoulou, E., Velissaris, D., et al. (2021) Atrial Fibrillation in Patients with Systolic Heart Failure: Pathophysiology Mechanisms and Management. Journal of Geriatric Cardiology, 18, 376-397.
- Li, N.N., Yin, Q. and Du, R.Z. (2021) Research Progress of Platelet Derived Growth Factor in Cardiovascular Diseases. Medical Review, 27, 3388-3393.
- Michael, B. and Kristian, P. (2018) PDGF Family Function and Prognostic Value in Tumor Biology. Biochemical & Biophysical Research Communications, 503, 984-990.